— Know what they know.
Not Investment Advice
Also trades as: 3401.T (JPX) · $vol 8M · TINLF (OTC) · $vol 0M

TINLY OTC

Teijin Limited
1W: +1.6% 1M: +0.0% 3M: +11.8% YTD: +24.4% 1Y: +17.8% 3Y: +8.4% 5Y: -30.9%
$10.45
+0.00 (+0.00%)
 
OTC · Industrials · Conglomerates · Tech Score Neutral · Power 59 · $2.0B mcap · 148M float · 0.0000% daily turnover · Short 64% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.0B
52W Range7.95-11.6
Volume50
Avg Volume9
Beta0.19
Dividend$0.25
Analyst Ratings
No analyst coverage
Company Info
CEOAkimoto Uchikawa
Employees15,689
SectorIndustrials
IndustryConglomerates
IPO Date1996-11-18
Websiteteijin.com
Kasumigaseki Common Gate West Tower
Tokyo, TY 100-8585
JP
81 3 3506 4529
About Teijin Limited

Teijin Limited is a global enterprise actively involved in various sectors, encompassing advanced fibers, films and sheets, composite materials, healthcare, and information technology. Within its materials divisions, the company manufactures a broad array of specialized products. These include high-performance fibers such as aramid and carbon fibers, alongside oxidized PAN fibers and diverse polyethylene-based materials. They also produce various films and sheets, specifically polycarbonate, high-density polyethylene porous films, and general microporous films. Furthermore, Teijin supplies engineering plastics like PC resins and polyphenylene sulfide resins, complete with associated molded components and additives. Their offerings extend to advanced composite solutions, notably lightweight glass and carbon fiber reinforced materials tailored for automotive applications. The materials portfolio is rounded out by polytrimethylene terephthalate products, artificial leather, polyester nanofibers, and sustainable recycled polyester fibers. Teijin's healthcare segment provides a comprehensive range of solutions. This includes pharmaceuticals for various ailments, particularly those affecting bone and joint health, the respiratory system, and cardiovascular and metabolic conditions. They also develop and distribute medical devices, such as home oxygen therapy equipment, non-invasive positive pressure ventilation (NPPV) devices, rehabilitation aids, and systems for sleep-disordered breathing. Other notable healthcare technologies feature a sonic accelerated fracture healing system and a community-based integrated care system. The company's healthcare offerings are further enhanced by orthopedic implantable devices and functional food ingredients. In the realm of information technology, Teijin offers Recopic, an advanced radio-frequency identification (RFID) solution designed for efficient inventory management. Additionally, the company is committed to developing and implementing engineering solutions to address critical global challenges, including environmental pollution, ensuring stable energy supplies, and mitigating the societal impacts of an aging workforce. Established in 1918, Teijin Limited maintains its corporate headquarters in Tokyo, Japan.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms